20 June 2013
Keywords: Hi-Tech, Mylan, Keppra, Lexapro, UCB, Forest Labs, USA, FDA
Article | 01 March 2012
US generic drugmaker Hi-Tech Pharmacal (Nasdaq: HITK) says that the US Food and Drug Administration has granted final approval for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 March 2012
19 June 2013
© 2013 thepharmaletter.com